United Therapeutics CEO Executes $5.3M Stock Sale Under Pre-Arranged Plan
Martine Rothblatt, chairperson and chief executive officer of United Therapeutics Corp (NASDAQ:UTHR), sold 9,500 shares of the company's common stock on July 7, 2026, for approximately $5.31 million. The sale followed the exercise of 9,500 stock options at $135.42 per share. The transactions were executed under a 10b5-1 trading plan adopted on Nove…